top of page
    • Jul 23, 2021
    • 1 min read

$315m biotech company emerges from stealth

🔥 Prime Medicine, a company with a powerful new gene editing technique, this week announced its official launch with $315 million in financing.

About The Company

Prime Medicine, a company with a powerful new gene editing technique, this week announced its official launch with $315 million in financing.





Heads up!! (We only share headlines with you finish the read below!

"Prime Editing is a wonderful example of the revolution in genetic medicine that we are living through," said Robert Nelsen, co-founder and Managing Director of ARCH Venture Partners, one of several companies to fund Prime Medicine. "Gene editing technologies like this, when mature, could totally change our conception of what's possible in treating disease."

Finish the read

https://lifeboat.com/blog/2021/07/315m-biotech-company-emerges-from-stealth

7 views0 comments

Recent Posts

See All

JAY DESANTIS JOINS REO CAPITAL AS A MANAGING PARTNER Who is Reo Capital? REO Capital is a global capital raising firm for Venture Capital and Private Equity Emerging Managers and Established Managers

Sea Topblue Cruise to $216,000 Andrew Bourns and Sea Topblue Cruise to $216,000 NetJets Grand Prix CSI4* Victory at 2022 WEF Wellington, FL – January 29, 2022 – The highlight of the week, the $216,000

The perks of being an early hirer Changing lives on the exchange Among them, over a dozen hold $10m+ worth of shares. That includes both long-time veterans like Alan Chang, who oversees operations at

bottom of page